Regulation of cathepsins S and L by cystatin F during maturation of dendritic cells

European Journal of Cell Biology

Volumn 91, Issue 5, 2012, Pages 391-401

  Magister, Špela ^a   Obermajer, Nataša ^a   Mirković, Bojana ^b   Švajger, Urban ^c   Renko, Miha ^a   Softić, Adaleta ^d   Romih, Rok ^b   Colbert, Jeff D ^e   Watts, Colin ^e   Kos, Janko ^a,b  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c BLOOD TRANSFUSION CENTRE OF SLOVENIA   (Slovenia)

^d UNIVERSITY OF TUZLA   (Bosnia and Herzegovina)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adhesion; Antigen presentation; Cathepsin; Cystatin F; Dendritic cell; Integrin receptor

Indexed keywords

CATHEPSIN H; CATHEPSIN L; CATHEPSIN S; CATHEPSIN X; CD11B ANTIGEN; CD18 ANTIGEN; CYSTATIN; INTEGRIN RECEPTOR; MONOMER;

ANTIGEN PRESENTATION; ARTICLE; CELL ADHESION; CELL MATURATION; CELL VACUOLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; ENDOSOME; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME REGULATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; LYSOSOME; MONOCYTE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; TRANSMISSION ELECTRON MICROSCOPY;

CATHEPSIN L; CATHEPSINS; CELL ADHESION; CELLS, CULTURED; CYSTATINS; DENDRITIC CELLS; ENDOSOMES; FEMALE; HUMANS; LYSOSOMES; MACROPHAGE-1 ANTIGEN; MALE; TUMOR MARKERS, BIOLOGICAL;

EID: 84857788537     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2012.01.001     Document Type: Article

References (55)

1. Abrahamson M. Cystatins. Methods Enzymol. 1994, 244:685-700.
2. Adkison A.M., Raptis S.Z., Kelley D.G., Pham C.T. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J. Clin. Invest. 2002, 109:363-371.
3. Alvarez-Fernandez M., Barrett A.J., Gerhartz B., Dando P.M., Ni J., Ambrahamson M. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J. Biol. Chem. 1999, 272:19195-19203.
4. Bakke O., Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990, 63:707-716.
5. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
6. Bevec T., Stoka V., Pungercic G., Dolenc I., Turk V. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J. Exp. Med. 1996, 183:1331-1338.
7. Burns S., Hardy S.J., Buddle J., Yong K.L., Jones G.E., Thrasher A.J. Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil. Cytoskeleton 2004, 57:118-132.
8. Cappello F., Gatti E., Camossetto V., David A., Lelouard H., Pierre P. Cystatin F is secreted, but artificial modification of its C-terminus can induce its endocytic targeting. Exp. Cell Res. 2004, 297:607-618.
9. Chapman H.A. Endosomal proteolysis and MHC class II function. Curr. Opin. Immunol. 1998, 10:93-102.
10. Colbert J.D., Matthews S.P., Kos J., Watts C. Internalisation of exogenous cystatin F suppresses cysteine proteases and induces the accumulation of single-chain cathepsin L by multiple mechanisms. J. Biol. Chem. 2011, 286:42082-42090.
11. Colbert J.D., Plechanovova A., Watts C. Glycosylation directs targeting and activation of cystatin F from intracellular and extracellular sources. Traffic 2009, 10:425-437.
12. Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 1994, 12:259-293.
13. Denzin L.K., Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995, 82:155-165.
14. Dolinar M., Maganja D.B., Turk V. Expression of full-length human procathepsin L cDNA in Escherichia coli and refolding of the expression product. Biol. Chem. Hoppe-Seyler 1995, 376:385-388.
15. El-Sukkari D., Wilson N.S., Hakansson K., Steptoe R.J., Grubb A., Shortman K., Villadangos J.A. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. J. Immunol. 2003, 171:5003-5011.
16. Gaidano G., Bergui L., Schena M., Gaboli M., Cremona O., Marchisio P.C., Caligaris-Cappio F. Integrin distribution and cytoskeleton organization in normal and malignant monocytes. Leukemia 1990, 4:682-687.
17. Guncar G., Pungercic G., Klemencic I., Turk V., Turk D. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. EMBO J. 1999, 18:793-803.
18. Halfon S., Ford J., Foster J., Dowling L., Lucian L., Sterling M., Xu Y., Weiss M., Ikeda M., Liggett D., Helms A., Caux C., Lebecque S., Hannum C., Menon S., McClanahan T., Gorman D., Zurawski G. Leukocystatin, a new class II cystatin expressed selectively by hematopoietic cells. J. Biol. Chem. 1998, 273:16400-16408.
19. Hamilton G., Colbert J.D., Schuettelkopf A.W., Watts C. Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis. EMBO J. 2008, 27:499-508.
20. Hashimoto S., Suzuki T., Dong H.Y., Nagai S., Yamazaki N., Matsushima K. Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood 1999, 94:845-852.
21. Hashimoto S., Suzuki T., Nagai S., Yamashita T., Toyoda N., Matsushima K. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood 2000, 96:2206-2214.
22. Honey K., Rudensky A.Y. Lysosomal cysteine proteases regulate antigen presentation. Nat. Rev. Immunol. 2003, 3:472-482.
23. Kos J., Krasovec M., Cimerman N., Nielsen H.J., Christensen I.J., Brunner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin. Cancer Res. 2000, 6:505-511.
24. Kos J., Sekirnik A., Kopitar G., Cimerman N., Kayser K., Stremmer A., Fiehn W., Werle B. Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis. Br. J. Cancer 2001, 85:1193-1200.
25. Kos J., Stabuc B., Schweiger A., Krasovec M., Cimerman N., Kopitar-Jerala N., Vrhovec I. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin. Cancer Res. 1997, 3:1815-1822.
26. Langerholc T., Zavasnik-Bergant V., Turk B., Turk V., Abrahamson M., Kos J. Inhibitory properties of cystatin F and its localization in U937 promonocyte cells. FEBS J. 2005, 272:1535-1545.
27. Lautwein A., Burster T., Lennon-Dumenil A.M., Overkleeft H.S., Weber E., Kalbacher H., Driessen C. Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells. Eur. J. Immunol. 2002, 32:3348-3357.
28. Le Naour F., Hohenkirk L., Grolleau A., Misek D.E., Lescure P., Geiger J.D., Hanash S., Beretta L. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J. Biol. Chem. 2001, 276:17920-17931.
29. Morita M., Hara Y., Tamai Y., Arakawa H., Nishimura S. Genomic constructs and mapping of the gene for CMAP (leukocystatin/cystatin F, CST7) and identification of a proximal novel gene, BSCv (C20orf3). Genomics 2000, 67:87-91.
30. Nakagawa T., Roth W., Wong P., Nelson A., Farr A., Deussing J., Villadangos J.A., Ploegh H., Peters C., Rudensky A.Y. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998, 280:450-453.
31. Nakagawa T.Y., Brissette W.H., Lira P.D., Griffiths R.J., Petrushova N., Stock J., McNeish J.D., Eastman S.E., Howard E.D., Clarke S.R., Rosloniec E.F., Elliott E.A., Rudensky A.Y. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 1999, 10:207-217.
32. Nathanson C.M., Wasselius J., Wallin H., Abrahamson M. Regulated expression and intracellular localization of cystatin F in human U937 cells. Eur. J. Biochem. 2002, 269:5502-5511.
33. Ni J., Fernandez M.A., Danielsson L., Chillakuru R.A., Zhang J., Grubb A., Su J., Gentz R., Abrahamson M. Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J. Biol. Chem. 1998, 273:24797-24804.
34. Obata-Onai A., Hashimoto S., Onai N., Kurachi M., Nagai S., Shizuno K., Nagahata T., Matsushima K. Comprehensive gene expression analysis of human NK cells and CD8+ T lymphocytes. Int. Immunol. 2002, 14:1085-1098.
35. Obermajer N., Švajger U., Bogyo M., Jeras M., Kos J. Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X. J. Leukoc. Biol. 2008, 84:1306-1315.
36. Odorizzi C.G., Trowbridge I.S., Xue L., Hopkins C.R., Davis C.D., Collawn J.F. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J. Cell. Biol. 1994, 126:317-330.
37. Pečar Fonović U., Kos J. Efficient removal of cathepsin L from active cathepsin X using immunoprecipitation technique. Acta Chim. Slov. 2009, 56:985-988.
38. Pham C.T., Ley T.J. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:8627-8632.
39. Pierre P., Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998, 93:1135-1145.
40. Pieters J., Bakke O., Dobberstein B. The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. J. Cell Sci. 1993, 106:831-846.
41. Puzer L., Cotrin S.S., Cezari M.H., Hirata I.Y., Juliano M.A., Stefe I., Turk D., Turk B., Juliano L., Carmona A.K. Recombinant human cathepsin X is a carboxymonopeptidase only: a comparison with cathepsins B and L. Biol. Chem. 2005, 386:1191-1195.
42. Rawlings N.D., Barrett A.J. Evolution of proteins of the cystatin superfamily. J. Mol. Evol. 1990, 30:60-71.
43. Riese R.J., Wolf P.R., Brömme D., Natkin L.R., Villadangos J.A., Ploegh H.L., Chapman H.A. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996, 4:357-366.
44. Schuttelkopf A.W., Hamilton G., Watts C., van Aalten D.M. Structural basis of reduction-dependent activation of human cystatin F. J. Biol. Chem. 2006, 281:16570-16575.
45. Schweiger A., Stabuc B., Popovic T., Turk V., Kos J. Enzyme-linked immunosorbent assay for the detection of total cathepsin H in human tissue cytosols and sera. J. Immunol. Methods 1997, 201:165-172.
46. Sherman M.A., Weber D.A., Jensen P.E. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 1995, 3:197-205.
47. Shi G.P., Villadangos J.A., Dranoff G., Small C., Gu L., Haley K.J., Riese R., Ploegh H.L., Chapman H.A. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 1999, 10:197-206.
48. Sivaraman J., Nägler D.K., Zhang R., Ménard R., Cygler M. Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine. J. Mol. Biol. 2000, 295:939-951.
49. Smyth M.J., McGuire M.J., Thia K.Y. Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I. J. Immunol. 1995, 154:6299-6305.
50. Stubbs M.T., Laber B., Bode W., Huber R., Jerala R., Lenarcic B., Turk V. The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J. 1990, 9:1939-1947.
51. Turk B., Turk D., Salvesen G.S. Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr. Pharm. Des. 2002, 8:1623-1637.
52. Turk V., Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 1991, 285:213-219.
53. Turkenburg J.P., Lamers M.B., Brzozowski A.M., Wright L.M., Hubbard R.E., Sturt S.L., Williams D.H. Structure of a Cys25→Ser mutant of human cathepsin S. Acta Crystallogr. D: Biol. Crystallogr. 2002, 58:451-455.
54. Vyas J.M., Van der Veen A.G., Ploegh H.L. The known unknowns of antigen processing and presentation. Nat. Rev. Immunol. 2008, 8:607-618.
55. Zavašnik-Bergant T., Repnik U., Schweiger A., Romih R., Jeras M., Turk V., Kos J. Differentiation- and maturation-dependent content, localization, and secretion of cystatin C in human dendritic cells. J. Leukoc. Biol. 2005, 78:122-134.